Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
J Brandt, A Khariouzov, J Listing, H Haibel… - The Journal of …, 2004 - jrheum.org
OBJECTIVE: Anti-tumor necrosis factor-a (TNF-alpha) therapy has been successfully used
in patients with active ankylosing spondylitis (AS) and other subtypes of spondyloarthritis (SpA…
in patients with active ankylosing spondylitis (AS) and other subtypes of spondyloarthritis (SpA…
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
BM Piraccini, U Blume‐Peytavi, F Scarci… - Journal of the …, 2022 - Wiley Online Library
Background Oral finasteride is a well‐established treatment for men with androgenetic
alopecia (AGA), but long‐term therapy is not always acceptable to patients. A topical finasteride …
alopecia (AGA), but long‐term therapy is not always acceptable to patients. A topical finasteride …
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo …
AF Hernandez, JB Green, S Janmohamed… - The Lancet, 2018 - thelancet.com
Background Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration
of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly …
of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly …
Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo‐controlled, 2‐way crossover polysomnography …
T Roth, DA Lankford, P Bhadra, E Whalen… - Arthritis care & …, 2012 - Wiley Online Library
Objective To assess the effect of pregabalin on polysomnographic (PSG) measures of sleep
and patient‐rated sleep, tiredness, and pain in fibromyalgia patients. Methods We …
and patient‐rated sleep, tiredness, and pain in fibromyalgia patients. Methods We …
Effect of anti‐IL‐1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo‐controlled …
A Rissanen, CP Howard, J Botha… - Diabetes, Obesity …, 2012 - Wiley Online Library
Aims Evaluate anti‐interleukin‐1β ( IL ‐1β) antibody, canakinumab, in patients with type 2
diabetes and impaired glucose tolerance ( IGT ) in whom hyperglycaemia may trigger IL ‐1β‐…
diabetes and impaired glucose tolerance ( IGT ) in whom hyperglycaemia may trigger IL ‐1β‐…
[HTML][HTML] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
G Bönner, GL Bakris, D Sica, MA Weber… - Journal of Human …, 2013 - nature.com
Drug therapy often fails to control hypertension. Azilsartan medoxomil (AZL-M) is a newly
developed angiotensin II receptor blocker with high efficacy and good tolerability. This double-…
developed angiotensin II receptor blocker with high efficacy and good tolerability. This double-…
Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials
A Fouque-Aubert, L Jette-Paulin… - Annals of the …, 2010 - ard.bmj.com
Background Tumour necrosis factor (TNF) blockers are known to increase the risk of serious
infections in rheumatoid arthritis. Despite wide use of TNF blockers in ankylosing spondylitis …
infections in rheumatoid arthritis. Despite wide use of TNF blockers in ankylosing spondylitis …
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
A Calin, BAC Dijkmans, P Emery, M Hakala… - Annals of the …, 2004 - ard.bmj.com
Objective: A double blind, randomised, placebo controlled study to evaluate the safety and
efficacy of etanercept to treat adult patients with ankylosing spondylitis (AS). Methods: Adult …
efficacy of etanercept to treat adult patients with ankylosing spondylitis (AS). Methods: Adult …
Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and methotrexate
J Sellam, Y Allanore, F Batteux, CJ Deslandre, B Weill… - Joint Bone Spine, 2005 - Elsevier
Objectives. – Induction of antinuclear antibodies (ANA) has been reported in patients taking
infliximab to treat refractory spondyloarthropathy, without concomitant methotrexate therapy. …
infliximab to treat refractory spondyloarthropathy, without concomitant methotrexate therapy. …
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
Introduction: Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory
approval for use in rheumatology: adalimumab, golimumab, infliximab, certolizumab, and …
approval for use in rheumatology: adalimumab, golimumab, infliximab, certolizumab, and …